Head-to-head · Value Score
Alan Meds vs NovoCare Pharmacy
Two GLP-1 deals, scored on the same six factors. Alan Meds lands a Value Score of 90, NovoCare Pharmacy a 75. Here's who gives you the honest lower price — and where each one bites back.
Alan Meds
#7 · Grade A · Best Value
Est. first month
$99/mo
Save ~93% vs brand-nameNovoCare Pharmacy
#134 · Grade C+ · Fair Price
Est. first month
From $149/mo (brand Wegovy, compounded oral)
Save ~89% vs brand-nameThe verdict
Alan Meds takes it on Value Score, 90 to 75 — an est. $99/mo first month, with no teaser step-up baked in. NovoCare Pharmacy isn't out of it: Shoppers who want branded Wegovy at the lowest manufacturer-direct self-pay price.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | Alan Meds | NovoCare Pharmacy |
|---|---|---|
| Value Score | 90 (A) | 75 (C+) |
| Est. first month | $99/mo | From $149/mo (brand Wegovy, compounded oral) |
| Save vs brand-name | ~93% | ~89% |
| Semaglutide | $99/mo | From $149/mo (brand Wegovy, compounded oral) |
| Tirzepatide | $145/mo | Not disclosed |
| Both molecules | Yes | No |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | All 50 states |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
Alan Meds
Double-digit semaglutide ($99) and a $145 tirzepatide, both nationwide, with an oral route for the needle-shy.
Why it's a deal
- $99 flat semaglutide and a low $145 tirzepatide
- Available in all 50 states
- Offers an oral/sublingual route
The fine print
- Not LegitScript-certified — do your own pharmacy diligence
- Newer operator with a thin public track record
NovoCare Pharmacy
Novo Nordisk's first-party direct-to-consumer pharmacy for branded Wegovy (semaglutide).
Why it's a deal
- First-party Novo Nordisk pharmacy — the most authoritative branded Wegovy channel
- $199/mo intro pricing on Wegovy 0.25/0.5 mg starter doses (through 6/30/2026), the lowest brand self-pay price
- $349/mo standard self-pay is well below the ~$1,300/mo retail list price
- Ships to all 50 states with no telehealth-platform middleman fees
- Cold-chain logistics handled directly by Novo Nordisk
The fine print
- Wegovy only — no Ozempic, no tirzepatide, no compounded GLP-1
- Requires an existing Wegovy prescription — no prescribing clinicians or telehealth intake
- No clinical support included — your own prescriber handles titration and side effects
- Manufacturer-set pricing can change at any time
- $199 pen intro covers only the first 2 fills for new patients (through 6/30/2026); maintenance doses are $349/mo ($399 HD)
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores Alan Meds is ranked on the Alan Meds alternatives board, and the same list for the other side is on alternatives to NovoCare Pharmacy.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.